CHEK1 and cancer: In this scenario, we highlighted the pivotal role in DNA damage signaling of RAD17 protein and recent literature demonstrated that RAD17 is a conserved key node for synthetic lethal interactions relevant for cancer therapy and specifically with cell cycle checkpoint kinases (40).